Global unmet psychosocial needs in cancer care: health policy.

Publication date: Dec 01, 2024

Preventable psychosocial suffering is an unmet need in patients with cancer around the world, significantly compromising quality of life and impairing cancer health outcomes. This narrative review overviews the global prevalence of emotional distress and cancer-related needs and the access barriers to psychosocial care. The COVID-19 pandemic has served only to amplify the need for psychosocial care, exacerbating the inadequacy of available psychosocial resources, particularly in low- and middle-income countries. Proposed solutions include implementing routine screening for emotional distress, addressing stigma related to mental health needs, and increased attention to the psychosocial dimensions of cancer care in oncology training and interprofessional models of care. There is an urgent need to address health policy issues such as resource allocation in cancer control plans and to embrace technological innovation in order to fill the universal gaps to providing more equitable psychosocial cancer care. None.

Open Access PDF

Concepts Keywords
Cancer Cancer-related needs
Eclinicalmedicine Distress screening
Pandemic Emotional distress
Psychosocial Psychosocial oncology
Universal

Semantics

Type Source Name
disease MESH cancer
disease IDO quality
disease MESH emotional distress
disease MESH COVID-19 pandemic
disease MESH anxiety
disease MESH depression
disease MESH adjustment disorders
disease MESH anxiety disorders
drug DRUGBANK Coenzyme M
disease IDO country
disease MESH mental disorders
disease MESH schizophrenia
disease MESH bipolar disorders
disease MESH personality disorders
disease MESH sequelae
disease MESH recurrence
disease MESH treatment failure
disease MESH end of life
disease IDO intervention
disease MESH morbidity
disease MESH emergency
disease MESH comorbidity
disease MESH lifestyle
disease MESH metastases
disease MESH suicide
disease MESH mesothelioma
drug DRUGBANK Trestolone
disease MESH violence
drug DRUGBANK Serine
disease IDO symptom
disease MESH uncertainty
disease IDO process
disease MESH tics
disease MESH hematological malignancies
disease MESH breast cancer
pathway KEGG Breast cancer
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH small cell lung cancer
pathway KEGG Small cell lung cancer

Original Article

(Visited 1 times, 1 visits today)